about
Understanding patients' perspective in the use of generic antiepileptic drugs: compelling lessons for physicians to improve physician/patient communication.Refilling and switching of antiepileptic drugs and seizure-related eventsGeneric products of antiepileptic drugs (AEDs): is it an issue?Generics and cost-effective prescribing in Belgium: does bioequivalence always translate in therapeutic equivalence?Exposure-response analysis reveals that clinically important toxicity difference can exist between bioequivalent carbamazepine tablets.Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.Demand-side policies to encourage the use of generic medicines: an overview.Safety and efficacy of valproic acid preparations.Comparison of dissolution profiles and serum concentrations of two lamotrigine tablet formulations.Cost-effectiveness of carbamazepine in epilepsy.Effects of antiepileptic drug substitutions on epileptic events requiring acute care.Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).Compulsory generic switching of antiepileptic drugs: high switchback rates to branded compounds compared with other drug classes
P2860
Q33418937-1043CC10-C1D5-4683-9CD7-0D9F8A38CC78Q34374193-368F99F8-B0F4-4D6E-B53D-7AC04DB42A26Q34582885-3F31AD76-F10B-43CA-AD22-99F7A89DB38CQ34614739-5CC1BE35-4560-4B1B-9F7C-AC744FD69F8EQ36536008-574CA8FC-B203-49F8-A02D-C6B90C90421DQ36713362-87863815-5514-46E7-BF10-031EF3841C2AQ37575533-8DDD4E4D-AE61-4A80-A6F8-FC9D46AEDEC1Q38080914-7B4A96D6-FD47-44B4-ACF7-3B91838EBE50Q40240175-94B10C7A-1DB0-4BD2-A7AD-D2D0B7C67A4BQ41963089-22B7C581-91BB-4FA4-AB84-9441B461E229Q43042774-F9941BF5-FBDA-481A-841B-9FF3B32C7BF0Q46238814-1ACC010F-7FD5-4E3F-BD7F-86813062A079Q47847824-5E1798CC-143A-4CAC-AE7A-0CF8DB3CFE00Q57041859-95991CBA-3442-477D-87BC-2F7FB1392E86
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Is generic prescribing acceptable in epilepsy?
@ast
Is generic prescribing acceptable in epilepsy?
@en
Is generic prescribing acceptable in epilepsy?
@nl
type
label
Is generic prescribing acceptable in epilepsy?
@ast
Is generic prescribing acceptable in epilepsy?
@en
Is generic prescribing acceptable in epilepsy?
@nl
prefLabel
Is generic prescribing acceptable in epilepsy?
@ast
Is generic prescribing acceptable in epilepsy?
@en
Is generic prescribing acceptable in epilepsy?
@nl
P1433
P1476
Is generic prescribing acceptable in epilepsy?
@en
P2093
P304
P356
10.2165/00002018-200023030-00001
P577
2000-09-01T00:00:00Z
P6179
1008748759